http://www.bing.com/news/search?q=orphan%26drug&setmkt=en-US&FORM=BNFD&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=orphan%26drug&setmkt=en-US&FORM=BNFD&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2ffinance.yahoo.com%2fsectors%2fhealthcare%2farticles%2fus-fda-grants-orphan-drug-110000286.html&c=3806699868971961715&mkt=en-usGEn1E Lifesciences Inc., a Phase 2 clinical-stage biotechnology company advancing AI-driven precision medicines for immunology, inflammation, and rare diseases, today announced that the U.S. Food and ...Tue, 09 Jun 2026 04:05:00 GMTYahoo Financehttp://www.bing.com/th?id=ONUT.V0xeWL3la95CnWV-l6aAng&pid=Newsw={0}&h={1}&c=14897345http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2ffinance.yahoo.com%2fsectors%2fhealthcare%2farticles%2fredhills-opaganib-receives-fda-rare-110000137.html&c=14940373837061641620&mkt=en-usRedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric ...Tue, 09 Jun 2026 04:37:00 GMTYahoo Financehttp://www.bing.com/th?id=ONUT.4RaVcYCgPxYd9rzFUohaog&pid=Newsw={0}&h={1}&c=14400226http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fwww.raps.org%2fresource%2fstudy-fda-approves-more-orphan-drugs-with-specific-cancer-pediatric-indications-over-ema.html&c=13270970103778366591&mkt=en-usThe US Food and Drug Administration (FDA) is more likely to approve drugs with an orphan designation that were indicated for subgroups of cancer or pediatric indications than the European Medicines ...Tue, 02 Jun 2026 13:08:00 GMTRegulatory Affairs Professionals Societyhttp://www.bing.com/th?id=ONUT.YmXdxlr-H-Ctqdz5Qxr-8A&pid=Newsw={0}&h={1}&c=141200675http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fmarkets.businessinsider.com%2fnews%2fstocks%2fquoin-pharmaceuticals-announces-japan-s-mhlw-grants-orphan-drug-designation-for-qrx003-in-netherton-syndrome-1036224984&c=15583465988214538735&mkt=en-usDesignation provides regulatory and development incentives in Japan, including up to 10 years of market exclusivity upon approval--Follows ...Thu, 04 Jun 2026 05:43:00 GMTMarkets Insiderhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fwww.bizjournals.com%2fsouthflorida%2fnews%2f2026%2f06%2f03%2fbiotech-fda-designation-als.html&c=13521266503518877460&mkt=en-usThe status incentivizes drug development by providing companies with financial subsidies, such as tax credits for clinical trials, regulatory benefits and the potential for seven years of market ...Wed, 03 Jun 2026 09:57:00 GMTThe Business Journalshttp://www.bing.com/th?id=ONUT.C-4YiKHgw3rFeWEpMXXKag&pid=Newsw={0}&h={1}&c=141200675http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fwww.businesswire.com%2fnews%2fhome%2f20250124756550%2fen%2fOrphan-Drugs-Strategic-Research-Report-2024-2030-A-Beacon-of-Hope-for-Patients-with-Rare-Diseases---Market-to-Reach-394.7-Billion-by-2030---ResearchAndMarkets.com%2f&c=13478105622928076950&mkt=en-usDUBLIN--(BUSINESS WIRE)--The "Orphan Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Orphan Drugs was estimated at US$179.5 ...Fri, 24 Jan 2025 06:24:00 GMTBusiness Wirehttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fwww.healthcarefinancenews.com%2fnews%2foptum-spotlights-orphan-drugs-drug-pipeline-report&c=13145885968536185902&mkt=en-usOptum is seeing an increase of new orphan drugs, and expects this trend to continue, if not accelerate, according to a drug pipeline report from the UnitedHealth Group subsidiary. What makes this ...Mon, 24 Oct 2022 09:45:00 GMTHealthcare Finance Newshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fwww.ajmc.com%2fview%2fpayer-coverage-of-orphan-drugs-often-varies-according-to-research-published-in-ithe-american-journal-of-managed-careisupregsup-&c=12081085358963564949&mkt=en-usRising number, cost of drugs for rare disease therapies create new pressure on health plans, researchers report in the October issue of The American Journal of Managed Care®. (CRANBURY, N.J.) — Drugs ...Mon, 07 Oct 2019 17:00:00 GMTThe American Journal of Managed Carehttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fwww.genengnews.com%2finsights%2fbig-pharma-reassesses-orphan-drug-sector%2f&c=13358728793974094080&mkt=en-usAs evidenced by the recent licensing deal between Pfizer and Protalix Biotherapeutics for the Gaucher disease treatment taliglucerase alfa, there is significant interest among big pharma companies in ...Sun, 28 Feb 2010 16:00:00 GMTGENhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fwww.raps.org%2fresource%2fstudy-orphan-drugs-more-innovative-than-non-orpha.html&c=4529300523503617611&mkt=en-usA recent study of orphan drugs approved by the US Food and Drug Administration (FDA) finds that orphan products are more innovative than their non-orphan counterparts, representing roughly 40% of ...Tue, 22 Mar 2016 17:00:00 GMTRAPShttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fwww.news-medical.net%2fnews%2f20230612%2fSo-called-e2809corphane2809d-drugs-earn-pharmaceutical-companies-as-much-money-as-mainstream-medicines.aspx&c=13433206214367741051&mkt=en-usDrugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public, according to a researcher at West Virginia University. Sean Tu, a ...Sun, 11 Jun 2023 17:00:00 GMTNews Medicalhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a282ca2cfca4fa48187f7a15a9aa256&url=https%3a%2f%2fwww.finanznachrichten.de%2fnachrichten-2026-06%2f68718281-redhill-biopharma-ltd-redhill-s-opaganib-receives-fda-rare-pediatric-disease-designation-for-neuroblastoma-in-addition-to-current-orphan-drug-design-008.htm&c=11419903983451010174&mkt=en-usThe U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to opaganib1 for the treatment of neuroblastoma, a type of cancer most commonly ...Tue, 09 Jun 2026 04:52:00 GMTFinanzNachrichten.de